Buerger's disease and intravenous administration of prostaglandins: A case report and review of the literature.

Autor: Meimeti, Evangelia, Lykoudi, Elissavet, Provatopoulou, Xeni, Moisoglou, Ioannis, Galanis, Petros, Galanis, Ioannis
Předmět:
Zdroj: Surgical Chronicles; Apr-Jun2022, Vol. 27 Issue 2, p240-242, 3p
Abstrakt: Background: Buerger's disease is a non-atherosclerotic inflammatory angiopathy, characterized as inflammatory endarteritis. It affects small and medium size arteries and veins of the upper and lower extremities, and is often associated with high amputation rates. Treatment of Buerger's disease remains rather challenging as most pharmacological therapies are unable to prevent disease progression. Case presentation: We present a case of a 65-year-old female patient with Buerger's disease who was successfully treated with prostaglandins in a public hospital of the capital city of Greece, Athens. Treatment was administered intravenously in-hospital for a total duration of 28 days. By the end of treatment, pain was better tolerated and lower limb ulcers had significantly improved. Follow-up evaluation revealed the patient's condition remained stable. Conclusion: Prostaglandins may play an important role in the treatment of the Buerger's disease. Intravenous administration of prostaglandins relieves pain, improves wound healing and reduces the rate of amputation in patients with Buerger's disease. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index